{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:48:54Z","timestamp":1793130534326,"version":"4.5.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.leukres.2009.06.012","type":"journal-article","created":{"date-parts":[[2009,7,26]],"date-time":"2009-07-26T10:10:21Z","timestamp":1248603021000},"page":"e234-e235","source":"Crossref","is-referenced-by-count":14,"title":["Nilotinib post-liver transplantation for acute hepatic failure related to imatinib"],"prefix":"10.1016","volume":"33","author":[{"given":"Guilherme F.","family":"Perini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio P.S.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaneuza","family":"Funke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben-Hur Ferraz","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Hamerschlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2009.06.012_bib1","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1056\/NEJMe030009","article-title":"Imatinib mesylate: the new gold standard for treatment of chronic myeloid leukemia","volume":"348","author":"Peggs","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2009.06.012_bib2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1182\/blood.V112.11.186.186","volume":"112","author":"O\u2019Brien","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.06.012_bib3","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-03-080689","article-title":"Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome\u2014positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance","volume":"110","author":"Kantarjian","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2009.06.012_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/shem.2003.50038","article-title":"Imatinib treatment: specific issues related to safety, fertility, and pregnancy","volume":"40","author":"Hensley","year":"2003","journal-title":"Semin Hematol"},{"key":"10.1016\/j.leukres.2009.06.012_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ajh.20486","article-title":"Imatinib mesylate as a cause of acute liver failure","volume":"81","author":"Cross","year":"2006","journal-title":"Am J Hematol"},{"issue":"13","key":"10.1016\/j.leukres.2009.06.012_bib6","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.3748\/wjg.v13.i48.6608","article-title":"Imatinib-induced fatal acute liver failure","volume":"28","author":"Ridruejo","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.leukres.2009.06.012_bib7","article-title":"Corticosteroids can reverse severe imatinib-induced hepatotoxicity","volume":"91","author":"Ferrero","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2009.06.012_bib8","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V112.11.3215.3215","article-title":"Minimal cross-intolerance between nilotinib and imatinib in patients with imatinib-intolerant chronic myeloid leukemia in chronic phase (CML-CP) or accelerated phase (CML-AP)","volume":"112","author":"Jabbour","year":"2008","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609002884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212609002884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:16:52Z","timestamp":1590020212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212609002884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0145212609002884"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2009.06.012","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}